Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
MYOMO, INC. (MYO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Kovelman Harry (Chief Medical Officer) has filed a Form 4 on MYOMO, INC.
Txns: Paid exercise price by delivering 123 shares @ $1.1, valued at $135.3
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/24/2023 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive ...
Docs: "Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims Appropriate payment amounts received on two MyoPro claims; Additional claims are under review while CMS rulemaking to re-classify the MyoPro to the brace benefit category progresses BOSTON ─ Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it has received payments for two claims submitted for MyoPro® arm braces provided to Medicare fee-for-service beneficiaries. Myomo recently delivered the custom-fabricated MyoPro braces to these two patients. After review of the medical documentation, one of Medicare’s billing contractors, referred to as a DME MAC, has covered and paid for these two..."
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics Q2 revenue of $6.0 million, including license revenue Nearly 1,000 prospective MyoPro® candidates with known payers in the patient pipeline Begins to build Medicare Part B patient pipeline following publication of proposed rule by the Centers for Medicare and Medicaid Services Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2023. Financial and operational highlights for the second quarter of 2023 include the following : &#x20..."
08/03/2023 4 Kovelman Harry (Chief Medical Officer) has filed a Form 4 on MYOMO, INC.
Txns: Paid exercise price by delivering 125 shares @ $0.71, valued at $88.8
08/02/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 4 Kovelman Harry (Chief Medical Officer) has filed a Form 4 on MYOMO, INC.
Txns: Paid exercise price by delivering 109 shares @ $0.6, valued at $65.4
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/30/2023 4 Mitchell Micah (Chief Commerical Officer) has filed a Form 4 on MYOMO, INC.
Txns: Granted 80,000 shares @ $0
06/30/2023 4 Kovelman Harry (Chief Medical Officer) has filed a Form 4 on MYOMO, INC.
Txns: Granted 80,000 shares @ $0
06/30/2023 4 HENRY DAVID A (CFO) has filed a Form 4 on MYOMO, INC.
Txns: Granted 130,000 shares @ $0
06/30/2023 4 GUDONIS PAUL R (CEO) has filed a Form 4 on MYOMO, INC.
Txns: Granted 250,000 shares @ $0
06/30/2023 4 Morris Milton Mayo (Director) has filed a Form 4 on MYOMO, INC.
Txns: Granted 59,988 shares @ $0
06/30/2023 4 Knapp Amy K. (Director) has filed a Form 4 on MYOMO, INC.
Txns: Granted 59,988 shares @ $0
06/30/2023 4 KIRK THOMAS F (Director) has filed a Form 4 on MYOMO, INC.
Txns: Granted 59,988 shares @ $0
06/30/2023 4 Crowley Thomas Aloysius Jr. (Director) has filed a Form 4 on MYOMO, INC.
Txns: Granted 59,988 shares @ $0
06/30/2023 4 Crowley Thomas Aloysius Jr. (Director) has filed a Form 4 on MYOMO, INC.
Txns: Sold 3,500 shares @ $2.286, valued at $8k
Sold 3,000 shares @ $2.147, valued at $6.4k
Sold 110 shares @ $2.146, valued at $236.1
Sold 6,000 shares @ $1.965, valued at $11.8k
Sold 291 shares @ $1.668, valued at $485.4
06/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/12/2023 4 Kovelman Harry (Chief Medical Officer) has filed a Form 4 on MYOMO, INC.
Txns: Paid exercise price by delivering 5,105 shares @ $0.463, valued at $2.4k
Paid exercise price by delivering 499 shares @ $0.4611, valued at $230.1
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/06/2023 4 Kovelman Harry (Chief Medical Officer) has filed a Form 4 on MYOMO, INC.
Txns: Paid exercise price by delivering 125 shares @ $0.55, valued at $68.8
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue Implementation of virtual waiting room technology enabled a record 438 patients added to the pipeline, up 54% over Q1 2022 Advertising efficiencies resulted in cost per pipeline add of $1,579, down 50% sequentially Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2023. Financial and operational highlights for the first quarter of 2023 include the following: • Product revenue was $3.4 million, up 20% compared with the prior year quarter..."
05/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2023 144 Form 144 - Report of proposed sale of securities:
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/03/2023 4 Kovelman Harry (Chief Medical Officer) has filed a Form 4 on MYOMO, INC.
Txns: Paid exercise price by delivering 129 shares @ $0.73, valued at $94.2
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy